SHANGHAI, China, July 11 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today proudly announced that it has won the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. The Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology is awarded to the company that has demonstrated commendable success in forming strategic partnerships with global clients for outsourced laboratory and research manufacturing services in drug discovery and development in pharmaceuticals and biotechnology.
Quality of scientists and personnel, service portfolio, quality of services, speed of service delivery, cost competitiveness, past experience and referrals are the selection criteria that Frost & Sullivan used. According to Frost & Sullivan, WuXi has excelled in the delivery of high-quality services in a timely manner and at competitive costs through a team of proficient scientists supported by world-class management.
"Until January, 2008, WuXi PharmaTech had provided services to more
than 700 global clients, with coverage of pharmaceutical, biotechnology and
medical devices. High proportion of repeat and referral customers is a
testament to its focus on customer satisfaction and operation excellence,"
said Frost & Sullivan Leader of China Healthcare Operation Mr. Xuchao Hou.
"The main contributing fact
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2008 PR Newswire.
All rights reserved